Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Craneware
Craneware Announces Year End Results from London Stock Exchange
October 12th, 2008
Craneware plc, (AIM: CRW) a leading provider of financial performance improvement software for hospitals and health systems, is pleased to announce final results for the fiscal year, which ended on June 30. Financial Highlights -- Revenues increased by 24 percent to $18.7m (2007: $15.1) -- Profit (before share based payments, depreciation and amortization) increased to $4.5m (2007: $3.8m) -- Profit after tax increased to $4.2m (2007: $1.8m) -- Basic EPS increased to $0.14 (2007: $0.06) and diluted to $0.13 (2007: $0.05) -- Dividend of 3.1p per share ...
Source: Pharma Investments, Ventures & Law Weekly (2008-10-12)
|
